Navigation Links
Differing reactions to anti clotting drugs may be due to genetic variation.,,

People who take anti clotting drugs like warfarin may react differently to the drug because of their genetic makeup.//

A sizable population of the world takes anti clotting medications in the event of heart attacks, stroke or major surgery to check harmful clotting of blood. However the difference in the reactions to the drugs have foxed the physicians for long and made it difficult to standardize the proper dosage of the drug. A little change in dose often may result in more reactions to blood flow.

Researchers of University of Washington in Seattle had discovered the variations in a gene that alters the way people respond to blood clotting medications. The gene encodes the CYP2C9 enzyme that metabolizes the anti clot drug and thus accounts for almost 10% variations of the reactions to the drug warfarin.

When are patients are tested for variations in reactions to medications, the tests mostly concentrate on the sex, age, weight and medical history of the patients. It may take months of visits to the physicians to find out the right dose for the patient even then. Genetic variations are often not considered here. The new research will emphasize the study of people’s reaction to medications and their genetic coding, also called pharmacogenetics.

Reference: National Institutes of Health, news release, June 2005
'"/>




Page: 1

Related medicine news :

1. Differing Ideas on Management of Alzheimer’s diseas
2. ZYBAN, The smoking cessation drug marked for its adverse reactions
3. Lupin flour may cause peanut allergy like reactions
4. Arsenic poisoning reactions can be traced to genes
5. stents Result in allergic reactions
6. Aspirin surpasses Modern Anti-clotting Drugs
7. Enduring anti-clotting treatment avails heart patients
8. Treatment over a longer period for blood clotting
9. Gum disease may be caused by blood clotting gene
10. Anlene brand of milk products will carry warnings about blood-clotting risks
11. Bivalirudin, a new anti-clotting drug may be a safer option for treatment of acute coronary conditions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/24/2017)... ... 24, 2017 , ... “The Gospel Truth Of The Bible: The Other Sheep”: the ceremonial laws ... Bible: The Other Sheep” is the creation of published author, Maurice Caines. Maurice Caines ... He has been a member of the Seventh-day Adventist Church for many years. ...
(Date:9/22/2017)... ... September 22, 2017 , ... MEDIA OPPORTUNITY: , Save Our Hospital - Albert ... why they are rallying against Mayo Clinic. Specifically, media can talk to steering committee ... (CEO) decision to close the Albert Lea hospital. , The rally aims to protect ...
(Date:9/22/2017)... Island, New York (PRWEB) , ... September 22, ... ... manufactures, delivers and assembles Passive House buildings, and Richard Pedranti Architect ... Prefabricated Passive House from the strategic partner’s Solsken Line of Model Homes ...
(Date:9/22/2017)... ... ... Happy Living’s mission - to improve the health and wellbeing of the ... delicious worlds of theatre and wines. , After watching Scott Barry perform on ... play into a book. The Greener The Grass ( https://www.happyliving.com/books/the-greener-the-grass ) was published on ...
(Date:9/22/2017)... ... September 22, 2017 , ... First Choice ... celebrating the one year anniversary of its Houston-Fallbrook facility. , “We are ... Facility Medical Director of First Choice Emergency Room Houston-Fallbrook. “It has been a ...
Breaking Medicine News(10 mins):
(Date:9/6/2017)... , Sept. 6, 2017  Medical professionals ... and skills while treating their patients. Medical ... experience without involving patients. Simulation provides a ... can carry out procedures, refine techniques and ... Integration of new technology, such as augmented ...
(Date:9/6/2017)... 2017 NeuroRx, a clinical stage biopharma company developing ... (ASIB), has been granted Fast Track status by the US ... (ketamine HCl) followed by NRX-101 (D-cycloserine + lurasidone). The company ... this sequential therapy targeting patients who are admitted to Emergency ... ...
(Date:9/5/2017)... Colo. , Sept. 5, 2017 Sapheneia ... XR-29 DoseCheck solution. Scannerside DoseCheck is a third-party Vendor ... existing CT scanners and allows compliance with current MITA ... Sapheneia-Scannerside proprietary XR 29 DoseCheck solution is specifically designed ... and alerts of potential radiation doses over a predefined ...
Breaking Medicine Technology: